BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260625T172229EDT-8394pH2tV6@132.216.98.100
DTSTAMP:20260625T212229Z
DESCRIPTION:Vasan S. Ramachandran\, MD\, FACC\, FAHA\n\nFounding Dean | Sch
 ool of Public Health |\n\nUniversity of Texas\n\nWHERE: In-Person | 2001 M
 cGill College\, Rm 1140\n\nNOTE: Social with Faculty & Students Rm 1147 2:
 30-3:00 pm\n\nAbstract\n\n\n	Health is influenced by hierarchical interdepe
 ndencies between built & socio-cultural environments (macro level)\, perso
 nal behaviors (meso level)\, & molecular and physiological factors (micro 
 level)\n	Health disparities are driven by health inequities\, i.e.\, resour
 ce-poor social environments & the policies\, programs & economic arrangeme
 nts that shape such environments\n	Public health problems are ‘wicked probl
 ems’\, best tackled with complex systems thinking\, collaboration\, dialog
 ue\, and shared understanding\n	Achieving health equity at scale requires a
  systems approach that targets the social determinants of health and shift
 s the distribution of power\, money\, and resources\n	Effective health prom
 otion and illness prevention require multifaceted\, multisectoral populati
 on-wide approaches to reshape the environments in which people live and in
  which they make choices via a combination of legislative\, policy\, and l
 egal responses\n	‘To health’ at scale requires us ‘to citizen’ at scale\n\n
 \nLearning Objectives\n\n\n	To understand concepts of structural and social
  determinants of health and their relations to health inequities and healt
 h disparities and the importance of structural competence\n	To understand c
 ommercial and legal determinants of health and their relations to health i
 nequities and disparities\n	To describe how to integrate social determinant
 s of health into healthcare\n\n\nSpeaker Bio\n\nI am a cardiologist with s
 ubspecialty training in echocardiography and cardiovascular epidemiology\,
  and have a long-standing commitment to clinical epidemiological research.
  I am the Founding Dean of the School of Public Health in San Antonio\, Te
 xas\, and a Professor Medicine and Population Health at the University of 
 Texas Health Science Center in San Antonio\, Texas. Previously\, I served 
 as the Chief in the Section of Preventive Medicine and Epidemiology in the
  Department of Medicine and Professor of Medicine and Epidemiology at Bost
 on University Schools of Medicine (BUSM) and Public Health (BUSPH). I also
  served as m the Principal Investigator of the Framingham Heart Study (FHS
 \, the oldest running epidemiology study in the US) between 2014 to 2022. 
 I am the Principal Investigator of the Risk Underlying Rural Areas Longitu
 dinal (RURAL) Study (one of the youngest cohort studies in the US). I also
  direct the FHS echocardiography-vascular imaging laboratory. I have been 
 an Associate Editor for Circulation\, the flagship journal of the American
  Heart Association\, from 2002-2016\, and I was the founding editor-in-chi
 ef for its daughter journal\, Circulation Cardiovascular Genetics from 200
 8-2018. I am a trained mentor and served as the PI of a Post-doc T32 progr
 am in ‘Interdisciplinary Training in Cardiovascular Epidemiology’ (from 20
 16-2022)\, and the PI of BU’s R38 program (Stimulating Access to Research 
 in residency) from 2020-2022\, which is focused on training medical reside
 nts in research.\n\nMy own research is focused on: A) The epidemiology and
  novel risk markers of heart failure (HF)\, with a focus on HFpEF\, includ
 ing evaluating the role of LV and vascular remodeling and ventricular-vasc
 ular coupling\; B) Population-based echocardiography and arterial stiffnes
 s\, including identifying biological\, environmental\, and genetic determi
 nants\, normative standards and prognostic implications\; C) Population-ba
 sed exercise testing\, with a current focus on cardiopulmonary exercise te
 sting with metabolite profiling\; D) Detailed assessment of novel biomarke
 rs of CVD risk\, risk prediction\, subclinical atherosclerosis and genomic
 s of CVD traits\, including metabolomics\, proteomics and the microbiome.
 \n\nZoom\n
DTSTART:20230320T200000Z
DTEND:20230320T210000Z
SUMMARY:How ‘to health’ at scale: Reflections in the post-pandemic era
URL:/epi-biostat-occh/channels/event/how-health-scale-
 reflections-post-pandemic-era-346911
END:VEVENT
END:VCALENDAR